Repaglinide
Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitation of Use: Repaglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
United States
$6
per month
India
$0
per month
You save
−92%save $5/mo · 92% cheaper
360.3K US scripts/yr$1.8M potential annual savings$2M US spend/yr
Drag to rotate · 3D structureC27H36N2O4
SMILES: CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
Compare the price
US price$6per month
India price$1per month
You save$582% less
Based on 30 units per month. US $0.19 vs India $0.03 per unit.
Total over 1 periodSave $5$6 → $1
The bigger picture
Repaglinide is filled about 360.3K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$2M
If sourced from India
$162.1K
Potential annual savings
$1.8M
−92%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.